Results 141 to 150 of about 9,994 (168)

Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors

Neuropharmacology, 2004
Maria F Cano-Abad, E Ales, Antonio Garcia Garcia   +2 more
exaly  

Galantamine

2019
Samia Kausar, Huda Ghulam Mustafa, Ataf Ali Altaf, Ghulam Mustafa, Amin Badshah   +4 more
openaire   +1 more source

Galantamin

2023
Helga Peter, Thomas Penzel
openaire   +1 more source

Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system

International Journal of Pharmaceutics, 2012
Chun-Woong Park, Yun-Seok Rhee, Ju-Young Kim   +2 more
exaly  

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease

Clinical Interventions in Aging, 2009
Ben Seltzer
exaly  

Galantamin

2010
Otto Benkert, Ion Anghelescu, Christoph Fehr, Gerhard Gründer, Philip Heiser, Christoph Hiemke, Christian Lange-Asschenfeldt, M. J. Müller, M. Paulzen, Francesca Regen, Axel Steiger   +10 more
openaire   +1 more source

Galantamine

Reactions Weekly, 2006
openaire   +2 more sources

Galantamine modulates nicotinic receptor and blocks Aβ-enhanced glutamate toxicity

Biochemical and Biophysical Research Communications, 2004
Hideyuki Sawada, Tomoki Nakamizo, Takeshi Kihara   +2 more
exaly  

Synthesis and Pharmacology of Galantamine

Chemical Reviews, 2006
Antonio Garcia Garcia, JOSÉ Marco-Contelles, Mercedes Villarroya   +2 more
exaly  

Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity

Bioorganic and Medicinal Chemistry, 2015
Mariyana Atanasova, Irini Doytchinova, Georgi Stavrakov   +2 more
exaly